ABVX CIK: 1956827

Abivax S.A.

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions EUR
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−41.4
FY22:
−64.8
FY23:
−127
FY24:
−173
FY25:
−246
(positive)
Change from FY24 to FY25
millions EUR
FY21:
–
FY22:
–
FY23:
–
FY24:
−165
FY25:
−269
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−42.5
FY22:
−60.7
FY23:
−148
FY24:
−176
FY25:
−330
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−42.5
FY22:
−60.7
FY23:
−148
FY24:
−176
FY25:
−336

All amounts in millions EUR Data sources:SEC EDGARTwelve Data